The Global Minimally Invasive Biopsy Technologies Market is projected to reach USD 3.98 billion in 2027. The market is expected to be driven due to a higher proliferation of the minimally invasive surgical procedures in biopsy testing and an extensive rise in the rate of breast and lung cancers globally. Around 66% of the total initial breast biopsies performed in North America are minimally invasive breast biopsies (MIBB).
A significant fraction of the overall open excisional biopsy has been replaced with minimally invasive biopsy approach in patients with unsettling or unclear breast lesions. Minimally invasive techniques for the biopsy can be used to achieve higher precision, which helps to decrease the psychological toll that patients endure and also greatly lowers the overall cost. Increased need for biopsy testing to detect cancerous cells, identify autoimmune, inflammatory, and infectious diseases, as well as the wide adoption of less invasive surgical methods. Early cancer detection and increased precision compared to incisional and excisional biopsies have been the constant drivers of this market.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/75
The Minimally Invasive Biopsy Technologies Market has undergone significant changes as a result of the coronavirus outbreak, which will likely limit future growth prospects for a number of suppliers and consumers. The paper talks about the market’s present state in addition to speculating about what might happen after COVID-19. In the end, the report provides conclusive information about the growth of the market for minimally invasive biopsy technologies as evaluated on a national and international scale.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Some Key Highlights from the Report
The ambulatory surgery centers have a more convenient outpatient procedure alternative to the hospital-based inpatient systems, maintaining a strong track record of quality care. Ambulatory surgery centers, incorporating all the required and modern MIB technologies, are expected to grow fastest amongst the end-use verticals throughout the forecast period.
The therapeutic application is further segmented into Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, and Non-oncology Application. Minimally invasive breast biopsy (MIBB) has been highly recommended for the pre breast cancer diagnosis and checkup globally. The MIBB is expected to grow higher during the projected period as the number of breast cancer increases.
The Asia Pacific region, due to its immense rise in the breast & lung cancers & rising usage of the MIB technologies, is expected to accelerate with the fastest growth rate of 20.1% during the projected period 2020 to 2027.
Buy your Exclusive copy@ https://www.emergenresearch.com/select-license/75
Major Companies in the Market Include:
Key players in the market include Chronix Biomedical, Biocept, Inc., F. Hoffmann-La Roche Ltd, Mauna Kea Technologies, Veracyte, Inc., Thermo Fisher Scientific, NeoGenomics Laboratories, Inc., Abcodia Ltd., Adaptive Biotechnologies, and Owlstone Medical Ltd., among others.
For the purpose of this report, Emergen Research has segmented into the global Minimally Invasive Biopsy Technologies Market on the basis of Technology, Therapeutic Application, End-Use Verticals, and region:
Technology Outlook (Revenue: USD Billion; 2017-2027)
- Liquid Biopsy
- Optical Biopsy
- Brush Biopsy
- Pigmented Lesion Assays
- Breath Biopsy
- Brush Biopsy
- Others
Therapeutic Application Outlook (Revenue: USD Billion; 2017-2027)
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Blood Cancer
- Non-oncology Applications
End-Use Verticals Outlook (Revenue: USD Billion; 2017-2027)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Others
Read Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/minimally-invasive-biopsy-technologies-market
Regional Outlook (Revenue, USD Billion; 2017–2027)
- North America
- S.
- Canada
- Mexico
- Europe
- Germany
- France
- K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Turkey
- Rest of MEA
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Access Sample copy @ Minimally Invasive Biopsy Technologies Market
Explore more reports offered by Emergen Research:
Electronic Skin Patches Market
Anti Fingerprint Coatings Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.